Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR).
Kessler DS, MacNeill SJ, Tallon D, Lewis G, Peters TJ, Hollingworth W, Round J, Burns A, Chew-Graham CA, Anderson IM, Shepherd T, Campbell J, Dickens CM, Carter M, Jenkinson C, Macleod U, Gibson H, Davies S, Wiles NJ.
Kessler DS, et al. Among authors: anderson im.
BMJ. 2018 Oct 31;363:k4218. doi: 10.1136/bmj.k4218.
BMJ. 2018.
PMID: 30381374
Free PMC article.
Clinical Trial.